Literature DB >> 17140216

Kinetics and mechanism of the oxidation of guanosine derivatives by Pt(IV) complexes.

Sunhee Choi1, Livia Vastag, Chin-Hin Leung, Adam M Beard, Darcy E Knowles, James A Larrabee.   

Abstract

The kinetics of redox reactions of the PtIV complexes trans-Pt(d,l)(1,2-(NH2)2C6H10)Cl4 ([PtIVCl4(dach)]) and Pt(NH2CH2CH2NH2)Cl4 ([PtIVCl4(en)]) with 5'- and 3'-dGMP (G) have been studied. These redox reactions involve substitution followed by an inner-sphere electron transfer. The substitution is catalyzed by PtII and follows the classic Basolo-Pearson PtII-catalyzed PtIV-substitution mechanism. We found that the substitutution rates depend on the steric hindrance of PtII, G, and PtIV with the least sterically hindered PtII complex catalyzing at the highest rate. 3'-dGMP undergoes substitution faster than 5'-dGMP, and [PtIVCl4(en)] substitutes faster than [PtIVCl4(dach)]. The enthalpies of activation of the substitution, DeltaH double dagger s, of 3'-dGMP is only 70% greater than that of 5'-dGMP (50.4 vs 30.7 kJ mol(-1)), but the entropy of activation of the substitution, DeltaS double dagger s, of 3'-dGMP is much greater than that of 5'-dGMP (-59.4 vs -129.5 J K(-1) mol(-1)), indicating that steric hindrance plays a major role in the substitution. The enthalpy of activation of electron transfer, DeltaH double dagger e, of 3'-dGMP is smaller than that of 5'-dGMP (88.8 vs 137.8 kJ mol(-1)). The entropy of activation of electron transfer, DeltaS double dagger e, of 3'-dGMP is negative, but that of 5'-dGMP is positive (-27.8 vs +128.8 J K-1 mol-1). The results indicate that 5'-hydroxo has less rotational barrier than 5'-phosphate, but it is geometrically unfavorable for internal electron transfer. The electron-transfer rate also depends on the reduction potential of PtIV. Because of its higher reduction potential, [PtIVCl4(dach)] has a faster electron transfer than [PtIVCl4(en)].

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17140216      PMCID: PMC2533113          DOI: 10.1021/ic061243g

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  18 in total

1.  A platinum(IV) complex oxidizes guanine to 8-oxo-guanine in DNA and RNA.

Authors:  S Choi; S Delaney; L Orbai; E J Padgett; A S Hakemian
Journal:  Inorg Chem       Date:  2001-10-22       Impact factor: 5.165

2.  Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase.

Authors:  P Kuzmic
Journal:  Anal Biochem       Date:  1996-06-01       Impact factor: 3.365

3.  Kinetics and mechanism for reduction of anticancer-active tetrachloroam(m)ine platinum(IV) compounds by glutathione.

Authors:  K Lemma; J Berglund; N Farrell; L I Elding
Journal:  J Biol Inorg Chem       Date:  2000-06       Impact factor: 3.358

4.  Contrasting chemistry of cis- and trans-platinum(II) diamine anticancer compounds: hydrolysis studies of picoline complexes.

Authors:  Geraldine McGowan; Simon Parsons; Peter J Sadler
Journal:  Inorg Chem       Date:  2005-10-17       Impact factor: 5.165

5.  Thermodynamic and kinetic studies on reactions of Pt(II) complexes with biologically relevant nucleophiles.

Authors:  Nadine Summa; Wolfgang Schiessl; Ralph Puchta; Nico van Eikema Hommes; Rudi van Eldik
Journal:  Inorg Chem       Date:  2006-04-03       Impact factor: 5.165

6.  Ground-state stability and rotational activation parameters for individual rotamers of (R,S,S,R)-(N,N'-dimethyl-2,3-diaminobutane)PtG(2) complexes (G = 9-EtG, 3'-GMP, and 5'-GMP).

Authors:  Gianpiero Colonna; Nicola G Di Masi; Luigi G Marzilli; Giovanni Natile
Journal:  Inorg Chem       Date:  2003-02-24       Impact factor: 5.165

7.  New Steric Hindrance Approach Employing the Hybrid Ligand 2-Aminomethylpiperidine for Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts Containing Guanine Derivatives.

Authors:  Hing C. Wong; Raymond Coogan; Francesco P. Intini; Giovanni Natile; Luigi G. Marzilli
Journal:  Inorg Chem       Date:  1999-02-22       Impact factor: 5.165

8.  Mechanism of two-electron oxidation of deoxyguanosine 5'-monophosphate by a platinum(IV) complex.

Authors:  Sunhee Choi; Richard B Cooley; Amanda S Hakemian; Yuna C Larrabee; Richard C Bunt; Stéphane D Maupas; James G Muller; Cynthia J Burrows
Journal:  J Am Chem Soc       Date:  2004-01-21       Impact factor: 15.419

9.  Platinum(II) catalysis and radical intervention in reductions of platinum(IV) antitumor drugs by ascorbic acid.

Authors:  Evelyne L Weaver; Rathindra N Bose
Journal:  J Inorg Biochem       Date:  2003-07-01       Impact factor: 4.155

10.  Kinetics and mechanism for reduction of the anticancer prodrug trans,trans,trans-[PtCl2(OH)2(c-C6H11NH2)(NH3)] (JM335) by thiols.

Authors:  K Lemma; T Shi; L I Elding
Journal:  Inorg Chem       Date:  2000-04-17       Impact factor: 5.165

View more
  3 in total

Review 1.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

Review 2.  Unusual DNA binding modes for metal anticancer complexes.

Authors:  Ana M Pizarro; Peter J Sadler
Journal:  Biochimie       Date:  2009-04-01       Impact factor: 4.079

3.  Oxidation of 5'-dGMP, 5'-dGDP, and 5'-dGTP by a platinum(IV) complex.

Authors:  Ioannis Kipouros; Sebastian Matias Fica-Contreras; Gregory Joon Kee Bowe; Sunhee Choi
Journal:  J Biol Inorg Chem       Date:  2015-11-21       Impact factor: 3.358

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.